Calif. biotech company once worth $476M lays off every remaining employee
After a year of dwindling coffers and repeated layoff rounds, the Southern California biotech firm Viracta Therapeutics has ...
stocknews21h
3 Biotech Stocks Revolutionizing Healthcare
Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...
FutureTech II Acquisition Corp. Restructures IPO Debt with Longevity Biomedical
FutureTech II Acquisition Corp. (NASDAQ:FTII), a special purpose acquisition company with a market capitalization of $59.58 million, has entered into an agreement with Longevity Biomedical Inc. and D.
FiercePharma2h
British biotech rebrands as Octavian, seeking to establish new empire after setbacks in 2024
Oxford Cannabinoid Technologies is shedding its old skin. Having delisted its stock last year, the biotech is rebranding as ...
Peninsula biotech moves from IPO to chopping half its workforce in little more than a year
After a nearly $300 million IPO little more than a year ago, a young Peninsula biotech company will discontinue what had been ...
Your Story6h
IXP launches Rs 200 Cr fund to support early-stage biotech startups
The fund aims to build a portfolio of 20-25 companies that address gaps in services and products across pharmaceuticals, ...
U.S. Biomedical Leadership Threatened By NIH Licensing Guidelines
New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...